Such atypical expression may reflect the following: (1) tumor dedifferentiation, resulting in partial phenotypic loss; (2) distinct molecular variants, possibly involving non‐TFE3 genetic events [9]; (3) technical factors, such as variations in antigen retrieval affecting melan‐A staining intensity. Here, TFE3 is linked to neoplasm.